Viral infections as a cause of Chronic Obstructive Pulmonary Disease (COPD) exacerbation;Infections virales à l'origine des exacerbations de la broncho-pneumopathie chronique obstructive

Praxis

Volumn 99, Issue 4, 2010, Pages 235-240

  Kherad, Omar ^a   Rutschmann, O T ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

COPD; Exacerbation; Virus

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; HEALTH CARE COST; QUALITY OF LIFE; SHORT SURVEY; UPPER RESPIRATORY TRACT; VIRUS IDENTIFICATION; VIRUS INFECTION;

EID: 77249108331     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/1661-8157/a000034     Document Type: Short Survey

References (33)

1. Calverley PM, Agusti A, Anzueto P, Bames P, Decramer Y, Fukuchi P, et al. The Global Strategy for Diagnosis, Management and Prevention of COPD (updated 2008). Global Initiative for chronic obstructive pulmonary disease (GOLD).www.goldcopd.com. Date last updated: November 2008. Date late accessed: February 2009.
2. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157(5 Pt 1):1418-22.
3. Donaldson GC, Wedzicha JA. COPD exacerbations .1: Epidemiology. Thorax 2006;61(2):164-8.
4. Wedzicha JA. Exacerbations: etiology and pathophysiologic mechanisms. Chest 2002;121 (5 Suppl):136S-141S. (Pubitemid 34497331)
5. Rosell A, Monso E, Soler N, Torres F, Angrill J, Riise G, et al.Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 2005;165(8):891-7. (Pubitemid 40563235)
6. Beckham JD, Cadena A, Lin J, Piedra PA, Glezen WP, Greenberg SB, et al. Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect 2005;50(4):322-30. (Pubitemid 40533369)
7. Camargo CA, Jr., Ginde AA, Clark S, Cartwright CP, Falsey AR, Niewoehner DE. Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease. Intern Emerg Med 2008; 3(4):355-9.
8. Cameron RJ, de Wit D, Welsh TN, Ferguson J, Grissell TV, Rye PJ. Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation. Intensive Care Med 2006;32(7):1022-9. (Pubitemid 43952717)
9. Greenberg SB, Allen M, Wilson J, Atmar RL. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162(1):167-73. (Pubitemid 30469815)
10. Hutchinson AF, Ghimire AK, Thompson MA, Black JF, Brand CA, Lowe AJ, et al. A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD. Respir Med 2007;101(12):2472-81. (Pubitemid 47618387)
11. Ko FW, Ip M, Chan PK, Chan MC, To KW, Ng SS, et al. Viral etiology of acute exacerbations of COPD in Hong Kong. Chest 2007;132(3):900-8.
12. Martinello RA, Esper F, Weibel C, Ferguson D, Landry ML, Kahn JS. Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease. J Infect 2006;53(4):248-54. (Pubitemid 44391059)
13. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006;173(10):1114-21. (Pubitemid 43726892)
14. Rohde G, Wiethege A, Borg I, Kauth M, Bauer TT, Gillissen A, et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 2003;58(1):37-42. (Pubitemid 36135356)
15. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164(9):1618-23. (Pubitemid 33124148)
16. Tan WC, Xiang X, Qiu D, Ng TP, Lam SF, Hegele RG. Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med 2003;115(4):272-7. (Pubitemid 37088188)
17. Smith CB, Golden CA, Kanner RE, Renzetti AD, Jr. Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis 1980;121(2):225-32. (Pubitemid 10095215)
18. Scott EJ, Grist NR, Eadie MB. Rhinovirus infections in chronic bronchitis: isolation of eight possibly new rhinovirus serotypes. J Med Microbiol 1968;1(1):109-17.
19. Wedzicha JA. Role of viruses in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004;1(2):115-20.
20. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999;130(5):397-403. (Pubitemid 29111221)
21. Mallia P, Message SD, Kebadze T, Parker HL, Kon OM, Johnston SL. An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study. Respir Res 2006;7:116.
22. Rohde G, Borg I, Wiethege A, Kauth M, Jerzinowski S, An Duong Dinh T, et al. Inflammatory response in acute viral exacerbations of COPD. Infection 2008;36(5):427-33.
23. Papadopoulos NG, Bates PJ, Bardin PG, Papi A, Leir SH, Fraenkel DJ, et al. Rhinoviruses infect the lower airways. J Infect Dis 2000;181(6): 1875-84. (Pubitemid 30416147)
24. Kherad O, Kaiser L, Bridevaux PO, Sarasin F,Thomas Y, Janssens J, et al. Viral Infections as a cause of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations. Abstract FM1, Basel, SGIM Session 1 2009.
25. Wilkinson TM, Hurst JR, Perera WR, Wilks M, Donaldson GC, Wedzicha JA. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest 2006;129(2):317-24. (Pubitemid 43289850)
26. Anthonisen N, Manfreda J, Warren C, Hershfield E, Harding G, Nelson N. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204. (Pubitemid 17009877)
27. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59(7):574-80. (Pubitemid 38901515)
28. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004;39(2):206-17. (Pubitemid 38971491)
29. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004;363(9409):600-7. (Pubitemid 38264177)
30. Briel M, Schuetz P, Mueller B, Young J, Schild U, Nusbaumer C, et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 2008;168(18):2000-7; discussion 2007-8.
31. Kristoffersen KB, Sogaard OS, Wejse C, Black FT, Greve T, Tarp B, et al. Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission - a randomized trial. Clin Microbiol Infect 2009;15(5):481-7.
32. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. Jama 2009;302(10):1059-66.
33. Stolz D, Christ-Crain M, Bingisser R, Leuppi J, Miedinger D, Muller C, et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 2007;131(1):9-19. (Pubitemid 46122969)